SEARO Technical Publication Series No. Additional and more specific guidance on the various areas related to clinical management of dengue from other sources in WHO and elsewhere are cited in the reference sections.
Dengue Guidelines For Diagnosis Treatment Prevention And Control
WHO 2011 Guideline of Dengue Infection 2.
Who dengue guidelines 2011. The Regional Guidelines were extensively revised updated and expanded with the focus on new and additional topics of current relevance to the populations of Member States of the Region. Undifferentiated fever Those who have been infected with dengue virus especially for the first time i e. Download Full PDF Package.
Dengue haemorrhagic fever DHF is characterized by four major clin-ical manifestations. WHO Regional Office for South-East Asia. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever.
In the last 50 years incidence has increased 30-fold with increasing geographic expansion to new countries and in the. Activities undertaken by WHO regarding dengue are most recently guided at the global policy level by World Health Assembly resolution WHA5517 adopted by the Fifty-fifth World Health Assembly in 2002 and at the regional level by resolution CE140R17 of the Pan American Sanitary Conference 2007 resolution WPRRC59R6 of the WHO Regional Committee for the Western Pacific 2008 and. Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever - revised and expanded edition.
Guidelines for diagnosis treatment prevention and control METHODOLOGY These guidelines were written using the following methodology. Revised and expanded edition. Guidelines on the quality safety and efficacy of dengue tetravalent vaccines live attenuated.
Guidelines for the Prevention and Control of DFDHF. Revised and expanded edition. Barniol J Gaczkowski R Barbato EV da Cunha RV Salgado D Martinez E et al 2011 Usefulness and applicability of the revised dengue case classification by disease.
World Health Organization 2009 Dengue. The non-WHO lead writers received a small fee for their work. An essential aspect of.
Writing team Each chapter was allocated to a WHO coordinator and at least one non-WHO lead writer. 37 Full PDFs related to this paper. Guidelines for diagnosis treatment prevention and control.
Revised and expanded edition. Dengue Guidelines for Diagnosis Treatment Prevention and Control New edition 2009WHO Geneva66. 60 2011 Unusual Dengue Expanded Dengue Syndrome - please see page 32 1 Asymptomatic Symptomatic Undifferentiated fever Viral Syndrome DF DHF Expanded dengue syndrome.
Collection storage and shipment. This revised and expanded edition of the Comprehensive Guidelines is intended to provide guidance to national and local-level programme managers and public health officials of Member States as well as other stakeholders including health practitioners laboratory personnel and multisectoral partners on strategic planning implementation monitoring and evaluation and strengthening the response to dengue. This handbook is not intended to replace national treatment training materials and guidelines but it aims to assist in the development of such materials produced at local national or regional level.
Guidelines on the quality safety and efficacy of dengue tetravalent vaccines live attenuated were adopted by ECBS in 2011. REVISED DENGUE CLINICAL CASE MANAGEMENT GUIDELINES 2011 I. Multi-centre study in 18 countries.
The development of a safe and effective dengue vaccine is a high priority and WHO supports this effort through technical guidance and advice. Comprehensive guidelines for prevention and control of dengue and Dengue Haemorrhagic Fever. WHO 2011 Guideline of Dengue Infection 2 Download.
Since then new strategies and developments in the control of dengue fever DHF and DSS have come to light. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. A short summary of this paper.
WHO recommends that countries should consider introduction of the dengue vaccine CYD-TDV only in geographic settings national or subnational where epidemiological data indicate a high burden of disease. Testing for dengue is recommended in persons who have a clinically compatible illness and have travelled to an area with known dengue activity during the. Dengue fever DF is an acute febrile viral disease frequently presenting with headaches bone or joint and muscular pains rash and leukopenia as symp-toms.
WHO 2011 Guideline of Dengue Infection 2 Motz Gaming. BACKGROUND and RATIONALE According to WHO dengue is the most rapidly spreading mosquito-borne viral disease in the world. Annex 2 Technical Report Series No.
S EARO Technical Publication Series No.
Pdf Guidelines For Clinical Case Management Of Dengue Fever Dengue Hemorrhagic Fever Dengue Shock Syndrome 2011 In Pakistan Context
Dengue Guideline 082012 Grade Dhf Dengue Indonesia
Usefulness And Applicability Of The Revised Dengue Case Classification By Disease Multi Centre Study In 18 Countries Bmc Infectious Diseases Full Text
Ourmedicalnotes Dengue Fever
Ida Safitri Laksono Dept Of Child Health Faculty Of Medicine Ugm Rsup Dr Sardjito Yogyakarta Ppt Download
Ida Safitri Laksono Dept Of Child Health Faculty Of Medicine Ugm Rsup Dr Sardjito Yogyakarta Ppt Download
Pdf Guidelines For Clinical Case Management Of Dengue Fever Dengue Hemorrhagic Fever Dengue Shock Syndrome 2011 In Pakistan Context
Http Www Pidsphil Org Home Wp Content Uploads 2017 02 13lec Incorporating The Revised Dengue Guidelines In General Pediatric Practice Pdf
Evaluation Of The Traditional And Revised Who Classifications Of Dengue Disease Severity
Dengue Guideline 082012 Grade Dhf Dengue Indonesia
Pdf Guidelines For Clinical Case Management Of Dengue Fever Dengue Hemorrhagic Fever Dengue Shock Syndrome 2011 In Pakistan Context
Comprehensive Guideline For Prevention And Control Of Dengue And Dengue Haemorrhagic Fever Revised And Expanded Edition
Dengue Fever And Dhf Who 2011
Https Apps Who Int Iris Rest Bitstreams 909932 Retrieve